$MGNX

2 stories mentioning MGNXUpdated 28d ago

Every FINWIRES story that references MGNX, newest first.

MacroGenics Closes Sale of Manufacturing Operations to Bora Pharmaceuticals

MacroGenics (MGNX) closed the sale of its good manufacturing practices drug substance manufacturing operations to Bora Pharmaceuticals for $122.5 million, the companies said Thursday.The transaction includes MacroGenics' manufacturing site and warehouse in Maryland, with Bora also absorbing 140 employees, according to a statement.Concurrently, the companies said they signed a supply agreement, under which Bora will support process development and drug substance production for MacroGenics' pipeline requirements.MacroGenics shares rose more than 3% in Thursday trading.Price: $4.78, Change: $+0.16, Percent Change: +3.35%

$MGNX

Research112d ago

B. Riley Upgrades MacroGenics to Buy From Neutral, Triples Price Target to $9 From $3

MacroGenics (MGNX) has an average rating of hold and mean price target of $4, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$MGNX

Track with the FINWIRES app suite

FolioX

Track MGNX in your portfolio

WheelAI

Analyze MGNX options with the wheel strategy

StockInsider

See market sentiment on MGNX